Concorde Financial’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-17,648
| Closed | -$1.18M | – | 37 |
|
|
2024
Q3 | $1.18M | Buy |
17,648
+448
| +3% | +$29.9K | 0.69% | 33 |
|
|
2024
Q2 | $2.04M | Buy |
17,200
+127
| +0.7% | +$15.1K | 1.34% | 29 |
|
|
2024
Q1 | $1.82M | Sell |
17,073
-3,062
| -15% | -$326K | 1.65% | 17 |
|
|
2023
Q4 | $2M | Buy |
+20,135
| New | +$2M | 1.37% | 30 |
|
|
2023
Q3 | – | Sell |
-21,273
| Closed | -$2.58M | – | 33 |
|
|
2023
Q2 | $2.58M | Sell |
21,273
-270
| -1% | -$32.8K | 1.69% | 30 |
|
|
2023
Q1 | $3.31M | Sell |
21,543
-717
| -3% | -$110K | 2.41% | 20 |
|
|
2022
Q4 | $2.63M | Hold |
22,260
| – | – | 1.78% | 25 |
|
|
2022
Q3 | $2.63M | Buy |
22,260
+5,809
| +35% | +$687K | 1.78% | 25 |
|
|
2022
Q2 | $2.35M | Sell |
16,451
-675
| -4% | -$96.4K | 2.62% | 18 |
|
|
2022
Q1 | $2.4M | Buy |
17,126
+2,378
| +16% | +$333K | 1.47% | 31 |
|
|
2021
Q4 | $3.49M | Buy |
+14,748
| New | +$3.49M | 2.19% | 22 |
|